Marburg Virus Outbreak Confirmed in Ethiopia
Outbreak Notification and Initial Findings
The Africa Centres for Disease Control and Prevention (Africa CDC) has confirmed a Marburg virus disease (MVD) outbreak in Jinka, located in Southern Ethiopia. This confirmation comes from the Ethiopian Federal Ministry of Health and the Ethiopian Public Health Institute (EPHI). As of November 14, 2025, the National Reference Laboratory has confirmed the presence of the virus, which shows genetic similarities to strains previously identified in East Africa.
The initial alert regarding a potential viral hemorrhagic fever was communicated to Africa CDC on November 12, 2025, prompting immediate attention and response.
Response Measures Activated
In light of the outbreak, the Ethiopian health authorities, alongside EPHI, have enacted several response strategies. These include enhanced surveillance measures, rigorous field investigations, and elevated infection prevention protocols. Community engagement efforts are also taking place, which are critical for informing the public and controlling the virus’s spread. The Africa CDC commends these swift actions and transparency in communication that facilitated the early confirmation of the outbreak, which is vital for effective containment.
Strengthening Diagnostic and Surveillance Capabilities
Africa CDC has a history of collaboration with EPHI aimed at fortifying Ethiopia’s capacity for molecular diagnostics and genomic surveillance. This partnership has proven essential in tackling the current outbreak. Africa CDC has supplied valuable resources, including genome-sequencing equipment, PCR detection kits tailored for Marburg, and comprehensive training for laboratory staff in various crucial areas such as bioinformatics and biosafety.
As part of strengthening Ethiopia’s laboratory capabilities, efforts have been enhanced through partnerships with organizations like the Global Fund, WHO, and the UK Health Security Agency. These collaborations aim to improve rapid laboratory confirmations and overall preparedness for future outbreaks.
Role of the Armauer Hansen Research Institute
The Armauer Hansen Research Institute (AHRI), a leading research institution in Ethiopia, has also benefited significantly from Africa CDC’s support. This includes the provision of necessary equipment, reagents, and focused training programs aimed at bolstering its research and genomic capabilities. AHRI is now in a pivotal position to contribute effectively during the Marburg outbreak, presenting opportunities not just for immediate care solutions but also for advancements in prevention, diagnostics, and treatment of the virus.
Joint Coordination Efforts
To enhance the efficiency of outbreak response, Africa CDC is working alongside the Ethiopian Ministry of Health to integrate Marburg virus response activities with ongoing preparations for mpox. By streamlining these efforts, they aim to maximize resources and bolster early detection systems, ultimately minimizing the chance of regional spread.
Continued Support and Cross-Border Coordination
In the coming days, Africa CDC Director-General, H.E. Dr. Jean Kaseya, will meet with Ethiopia’s Minister of Health to evaluate additional support necessary for tackling the Marburg outbreak. Discussions will also focus on reinforcing cross-border readiness with neighboring nations. Africa CDC remains committed to facilitating a coordinated and effective response, collaborating closely with the Ethiopian government and its partners throughout this crisis.
Future Updates
As the situation develops, Africa CDC will provide ongoing updates to keep the public informed and assist in the management of this outbreak effectively.
